Biotech Growth N V - Oct 21, 2022 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role: 10%+ Owner
Signature: /s/Ivo Betschart
Stock symbol: BDTX
Transactions as of: Oct 21, 2022
Transactions value $: $132,750
Form type: 4
Date filed: 10/25/2022, 04:24 PM
Previous filing: Oct 21, 2022
Next filing: Oct 28, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDTX	Common Stock	Purchase	$133K	+87.9K	+1.82%	$1.51	4.91M	Oct 21, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Black Diamond Therapeutics, Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.